Popular Stories
- Arcutis Biotherapeutics (N
- Nexgel: Bringing Innovatio
- Ekso Bionics: Advancing Ra
- Esperion: Revolutionizing
- AMSC: Restructuring the Po
- Harrow Inc: Envisioning a
SAMPLE REPORTS
- Company Summary.pdf
- Daily Market Updates.pdf
- Initiating Coverage.pdf
- Investors' Presentation.pdf
- Portfolio Performance Analysis.pdf
- Pre-Result Analysis.pdf
- Result Review.pdf
- Short Initiating Coverage.pdf

Roche Pharma Tag

  • All
  • Beauty
  • Biotechnology
  • Cannabis
  • Communications
  • Education
  • Energy
  • Entertainment
  • Environment
  • ETFs
  • Finance
  • Fitness
  • Food and Beverage
  • Healthcare
  • Hospitality
  • Insider Trading
  • Investing Ideas
  • Macro
  • Market Insight
  • Miscellaneous
  • Power
  • Real Estate
  • Retail
  • Sectors
  • Security
  • Startups
  • Technologies
  • Trending
  • Uncategorized
6 Reasons to Avoid Atea Pharmaceuticals
6 Reasons to Avoid Atea Pharmaceuticals

Termination of Collaboration with Roche Atea Pharmaceuticals, Inc. (NASDAQ: AVIR), a clinical-stage biopharmaceutical company, announced the termination of its strategic collaboration with Roche (OTCQX: RHHBY), for the joint development of AT-527, intended for the treatment of COVID-19. The agreement will be terminated on February 10,2022 and...

19 November, 2021 0 Comments
Pieris's Anticalin could be a Gamechanger!
Pieris’s Anticalin could be a Gamechanger!

Pieris Pharmaceuticals, Inc. (NASDAQ: PIRS) develops Anticalin-based drugs for treatment of conditions related to immuno-oncology and respiratory diseases such as Asthma and Anaemia. Anticalin proteins are engineered versions of lipocalins that are human proteins having the ability to bind, store and transport molecules, which the Company has...

11 October, 2021 0 Comments
WordPress Video Lightbox Plugin